期刊文献+

浅析中医辩证治疗糖尿病肾病的临床观察

Clinical Observation on TCM Syndrome Differentiation Treatment of Diabetic Nephropathy
下载PDF
导出
摘要 目的对糖尿病肾病患者接受临床中医治疗的效果开展分析研究,为临床治疗提供可靠依据。方法选取2017年1—12月该院接收的糖尿病肾病患者60例进行研究分析,将患者分组为对照组和实验组,两组均为30例,对照组患者接受西医治疗,实验组患者接受中医治疗,对两组的临床治疗情况开展比较分析。结果实验组的临床各项指标均要比对照组低,差异有统计学意义(P<0.05)。实验组临床有效率是93.33%,对照组有效率是73.33%,差异有统计学意义(P<0.05)。结论临床中糖尿病肾病采取中医治疗能够获得较好的效果,临床中可以进行推广使用,对患者的病情有比较好的改善效果。 Objective To analyze and study the effect of TCM syndrome differentiation treatment of diabetic nephropathy thus providing reliable reference for the clinical treatment. Methods 60 cases of patients with diabetic nephropathy admitted and treated in our hospital from January to December 2017 were selected for research and analysis, with 30 cases in each, the control group were treated with western medicine, while the experimental group were treated with TCM, and the clinical treatment situation was compared between the two groups. Results Various clinical indexes in the experimental group were lower than those in the control group, and the differences were statistically significant(P〈0.05), and the clinical effective rate in the experimental group and in the control group was respectively 93.33% and 73.33%, and the difference between the two groups was statistically significant(P〈0.05). Conclusion The effect of TCM treatment of diabetic nephropathy is better, which can be promoted and applied, and it has a better improvement effect in the diseases of patients.
作者 谷利民 GU Li-min(Department of Internal Medicine, Daqing Limin Hospital, Daqing, Heilongjiang Province, 163311 China)
出处 《糖尿病新世界》 2018年第8期191-192,共2页 Diabetes New World Magazine
关键词 中医治疗 糖尿病肾病 效果 TCM treatment Diabetic nephropathy Effect
  • 相关文献

参考文献5

二级参考文献116

  • 1刘慧丽,袁立,杨云青.醛糖还原酶遗传缺失可显著减缓C57BL/6小鼠糖尿病肾病进程[J].中华糖尿病杂志,2010,2(5). 被引量:5
  • 2谈力欣,王战建.肥胖与糖尿病肾病的发病机制[J].中华糖尿病杂志,2010,2(5). 被引量:2
  • 3中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5230
  • 4Yokoyama M, Tanigawa K, Murata T, et al. Dietary polyunsaturated fatty acids slow the progression of diabetic nephropathy in streptozotocin-induced diabetic rats. Nutr Res, 2010, 30: 217- 225.
  • 5Kuwabara T, Mori K, Mukoyama M, et al, Exacerbation of diabetic nephropathy by hyperlipidaemiais mediated by Toll- like receptor 4 in mice. Diabetologia, 2012, 55: 2256-2266.
  • 6Campbell KN, Rai JL, Mundel P. Role of anglotensin 11 in the development of nephropathy and podocytopathy of diabetes. Curt Diabetes Rev, 2011, 7: 3-7.
  • 7Kumar PA, Brosius FC 3rd, Menon RK. The glomerular podocyte as a target of growth hormone action:implications for the pathogenesis of diabetic nephropathy. Curr Diabetes Rev, 2011, 7: 50-55.
  • 8Romero M, Ortega A, Izquierdo A, et al. Parathyroid hormone- related protein induces hypertrophy in podocytes via TGF-beta (1) and p27(Kipl): implications for diabetic nephropathy. Nephrol Dial Transplant, 2010, 25: 2447-2457.
  • 9Nagase R, Kajitani N, Shikata K, et al. Phenotypic change of macrophages in the progression of diabetic nephropathy; sialoadhesin- positive activated macrophages are increased in diabetic kidney. Clin Exp Nephrol, 2012, 16: 739-748.
  • 10Elmarakby AA, Abdelsayed R, Yao Liu J, et al. Inflammatory cytokines as predictive markers for early detection and progression of diabetic nephropathy. EPMA J, 2010, 1: 117-129.

共引文献159

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部